PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA

• B. Kahl,
• J. Cohen,
• R. Pillai,
• V. Jayaprakash,
• C. Wang,
• M. Hahka-Kemppinen,
• M. Kania,
• P. Zinzani

Affiliations

B. Kahl

1 Washington University School of Medicine, St Loius

J. Cohen

2 Emory University School of Medicine, Atlanta

R. Pillai

3 HUTCHMED International Corporation, Florham Park, United States of America

V. Jayaprakash

3 HUTCHMED International Corporation, Florham Park, United States of America

C. Wang

3 HUTCHMED International Corporation, Florham Park, United States of America

M. Hahka-Kemppinen

3 HUTCHMED International Corporation, Florham Park, United States of America

M. Kania

3 HUTCHMED International Corporation, Florham Park, United States of America

P. Zinzani

4 University of Bologna Institute of Hematology, Bologna, Italy